Anticancer Therapies – News and Features

Research now shows that a chemofree drug-combination therapy is more effective and produces fewer side effects.

According to research, elevated bone biomarkers were associated with an increased risk of death in men with hormone-sensitive prostate cancer.

Children with an inoperable type of brain cancer may benefit from an advanced immunotherapy treatment, according to new research.

Research suggests that AI-based population screening could be valuable in finding those at elevated risk for pancreatic cancer and could expedite diagnosis.

A novel approach to treating cancer uses bacteria that naturally reside within tumors to trigger a powerful anticancer immune response.

Researchers have assembled a profile of all the genes and proteins that appear to be important in the process of metastasis.

Researchers have identified a strategy cancerous tumors use to remotely disrupt the development of an immune response that could stop their growth.

Nearly 90 percent of patients with an aggressive subtype of non-Hodgkin lymphoma had their cancer go into remission in a small phase 2 clinical trial testing a treatment aimed at making chemotherapy more effective.

In this article, we review the latest research in cell therapy development, including advances made in the lab that show promise for translation to the clinic, to improvements in developing, testing and manufacturing.

By using deep learning-generated ‘fingerprints’ to characterize millions of protein fragments, researchers have computationally designed novel protein binders that attach seamlessly to key targets, including the SARS-CoV-2 spike protein.